Ｍ－オンコリスバイオ：Announcement of First Patient Enrolled in Oncology Investigator-Initiated Phase 2 Clinical Trial for Telomelysin (OBP-301) of Head and Neck Cancer - 有報キャッチャー

Ｍ－オンコリスバイオ（4588）　Announcement of First Patient Enrolled in Oncology Investigator-Initiated Phase 2 Clinical Trial for Telomelysin (OBP-301) of Head and Neck Cancer 2021/05/06

/-

読み込み中…